Hera Health Solutions

Hera Health Solutions is a private, pre-revenue biotech firm developing a tunable nanofiber-based drug delivery platform capable of sustained release from days to years. The company is advancing a pipeline of long-acting subcutaneous implants and patches, primarily in women's health and substance use disorder, through internal programs and co-development/licensing partnerships. Its strategy is to collaborate with pharmaceutical companies to reformulate existing APIs, leveraging FDA/GMP-approved materials and manufacturing for a potentially streamlined regulatory path.

Proprietary biodegradable nanofiber scaffold platform for tunable, long-acting drug delivery, compatible with small molecules and biologics, adaptable to implants and patches.

Hera competes with other drug delivery platform companies (e.g., Delpor, Oakwood Labs, QLT) and large medical device/pharma firms with long-acting delivery divisions (e.g., Merck in implants, Titan Pharmaceuticals). Its focus on biodegradable nanofibers and tunable release profiles differentiates it from traditional polymer-based implants.